Impact of adenovirus-mediated local expression of human tissue factor pathway inhibitor on vascular smooth muscular cell proliferation and apoptosis in the stent-implanted femoral artery of the rabbit

Journal of International Medical Research

Volumn 36, Issue 3, 2008, Pages 567-571

  Zhang, Z Y ^a   Yin, Xin Hua ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; Proliferation; Stent implantation; Tissue factor pathway inhibitor gene

Indexed keywords

ADENOVIRUS VECTOR; ANTIBODY; BETA GALACTOSIDASE; CYCLINE; SODIUM CHLORIDE; TISSUE FACTOR PATHWAY INHIBITOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTERY INJURY; ARTERY MEDIA; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; FEMORAL ARTERY; GENE TRANSFER; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; IN-STENT RESTENOSIS; MALE; MITOSIS INHIBITION; NICK END LABELING; NONHUMAN; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SMOOTH MUSCLE FIBER; STENT; VASCULAR SMOOTH MUSCLE; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY; VIRUS RECOMBINANT;

EID: 45149124269     PISSN: 03000605     EISSN: None     Source Type: Journal    
DOI: 10.1177/147323000803600323     Document Type: Article

References (23)

1. Thyberg J: Phenotypic modulation of smooth muscle cells during formation of neointimal thickenings following vascular injury. Histol Histopathol 1998; 13: 871-891.
2. Liistro F, Colombo A: Late acute thrombosis after paclitaxel eluting stent implantation. Heart 2001; 86: 262-264.
3. Guagliumi G, Farb A, Musumeci G, et al: Images in cardiovascular medicine. Sirolimus-eluting stent implanted in human coronary artery for 16 months: pathological findings. Circulation 2003; 107: 1340-1341.
4. Serruys PW, Degertekin M, Tanabe K, et al: Intravascular ultrasound findings in the multicenter, randomized, double-blind RAVEL (RAndomized study with the sirolimus-eluting VElocity balloon-expandable stent in the treatment of patients with de novo native coronary artery Lesions) trial. Circulation 2002; 106: 798-803.
5. Camerer E, Kolstø AB, Prydz H: Cell biology of tissue factor, the principal initiator of blood coagulation. Thromb Res 1996; 81: 1-41.
6. Rapaport SI, Rao LVM: Initiation and regulation of tissue factor-dependent blood coagulation. Arterioscler Thromb 1992; 12: 1111-1121.
7. Poulsen LK, Jacobsen N, Sorensen BB, et al: Signal transduction via the mitogen-activated protein kinase pathway induced by binding of coagulation factor VIIa to tissue factor. J Biol Chem 1998; 273: 6228-6232.
8. 2+ signals in J82 cells, transfected COS-1 cells, Madin-Darby canine kidney cells and in human enclothelial cells induced to synthesize tissue factor. J Biol Chem 1995; 270: 4650-4660.
9. Broze GJ Jr, Girard TJ, Novotny WF: Regulation of coagulation by a multivalent Kunitz-type inhibitor. Biochemistry 1990; 29: 7539-7546.
10. Kamikubo Y, Nakahara Y, Takemoto S, et el: Human recombinant tissue-factor pathway inhibitor prevents the proliferation of cultured human neonatal aortic smooth muscle cells. FEBS Lett 1997; 407: 116-120.
11. Sato Y, Katooka H, Asada Y, et al: Overexpression of tissue factor pathway inhibitor in aortic smooth muscle cells inhibits cell migration induced by tissue factor/factor VIIa complex. Thromb Res 1999; 94: 401-406.
12. Hehrlein C, Zimmermann M, Pill J, et al: The role of elastic recoil after balloon angioplasty of rabbit arteries and its prevention by stent implantation. Eur Heart 1994; 15: 277-280.
13. Yin X, Yutani C, Ikeda Y, et al: Tissue factor pathway inhibitor gene delivery using HVJ-AVE liposomes markedly reduces restenosis in atherosclerotic arteries. Cardiovasc Res 2002; 56: 454-463.
14. Hamuro, T, Kamikubo Y, Nakahara Y, et al: Human recombinant tissue factor pathway inhibitor induces apoptosis in cultured human endothelial cells. FEBS Lett 1998; 421: 197-202.
15. Tasiou A, Konduri SD, Yanamandra N, et al: A novel role of tissue factor pathway inhibitor-2 in apoptosis of malignant human gliomas. Int J Oncol 2001; 19: 591-597.
16. Kato H: Regulation of functions of vascular wall cells by tissue factor pathway inhibitor: basic and clinical aspects. Arterioscler Thromb Vasc Biol 2002; 22: 539-548.
17. Ragni M, Golino P, Cirillo P, et al: Endogenous tissue factor pathway inhibitor modulates thrombus formation in an in vivo model of rabbit carotid artery stenosis and endothelial injury. Circulation 2000; 102: 113-117.
18. Nishida T, Ueno H, Atsuchi N, et al: Adenovirus-mediated local expression of human tissue factor pathway inhibitor eliminates shear stress-induced recurrent thrombosis in the injured carotid artery of the rabbit. Circ Res 1999; 84: 1446-1452.
19. Zoldhelyi P, McNatt J, Shelat HS, et al: Thromboresistance of balloon-injured porcine carotid arteries after local gene transfer of human tissue factor pathway inhibitor. Circulation 2000; 101: 289-295.
20. Atsuchi N, Nishida T, Marutsuka K, et al: Combination of a brief irrigation with tissue factor pathway inhibitor (TFPI) and adenovirus-mediated local TFPI gene transfer additively reduces neointima formation in bolloon-injured rabbit carotid arteries. Circulation 2001; 103: 570-575.
21. Huynh TT, Davies MG, Thompson MA, et al: Local treatment with recombinant tissue factor pathway inhibitor reduces the development of intimal hyperplasia in experimental vein grafts. J Vasc Sury 2001; 33: 400-407.
22. Roque M, Reis ED, Fuster V, et al: Inhibition of tissue factor reduces thrombus formation and intimal hyperplasia after porcine coronary angioplasty. J Am Coll Cardiol 2000; 36: 2303-2310.
23. Zoldhelyi P, Chen ZQ, Shelat HS, et al: Local gene transfer of tissue factor pathway inhibitor regulates intimal hyperplasia in atherosclerotic arteries. Proc Natl Acad Sci USA 2001; 27: 4078-4083.